ALIGN TECHNOLOGY, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 300.8 USD | +0.62% |
|
-1.29% | +9.79% |
| Apr. 18 | Stifel Nicolaus Adjusts Align Technology Price Target to $400 From $350 | MT |
| Apr. 15 | UBS Raises Align Technology Price Target to $320 From $280, Maintains Neutral Rating | MT |
Financials (USD)
| Sales 2024 * | 4.05B | Sales 2025 * | 4.46B | Capitalization | 22.64B |
|---|---|---|---|---|---|
| Net income 2024 * | 541M | Net income 2025 * | 624M | EV / Sales 2024 * | 5.26 x |
| Net cash position 2024 * | 1.36B | Net cash position 2025 * | 1.54B | EV / Sales 2025 * | 4.74 x |
| P/E ratio 2024 * |
42
x | P/E ratio 2025 * |
36
x | Employees | 21,610 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.46% |
More Fundamentals
* Assessed data
More news
Latest transcript on Align Technology, Inc.
More recommendations
More press releases
More news
| 1 day | +0.62% | ||
| 1 week | -1.29% | ||
| Current month | -8.26% | ||
| 1 month | -5.82% | ||
| 3 months | +10.75% | ||
| 6 months | +11.46% | ||
| Current year | +9.79% |
1 week
296.50
308.00
1 month
296.50331.64
Current year
250.28335.40
1 year
176.34413.20
3 years
172.05737.45
5 years
127.88737.45
10 years
43.27737.45
| Managers | Title | Age | Since |
|---|---|---|---|
Joseph Hogan
CEO | Chief Executive Officer | 65 | 15-05-31 |
John Morici
DFI | Director of Finance/CFO | 57 | 16-11-09 |
Zelko Relic
CTO | Chief Tech/Sci/R&D Officer | 59 | 13-12-01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
George Morrow
BRD | Director/Board Member | 72 | 06-01-31 |
Joseph Hogan
CEO | Chief Executive Officer | 65 | 15-05-31 |
Kevin Conroy
BRD | Director/Board Member | 58 | Dec. 04 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.49% | 16 M€ | -7.93% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-22 | 300.8 | +0.62% | 446,836 |
| 24-04-19 | 299 | -0.78% | 520,396 |
| 24-04-18 | 301.3 | +0.40% | 417,217 |
| 24-04-17 | 300.1 | -1.63% | 574,960 |
| 24-04-16 | 305.1 | +0.12% | 502,777 |
Delayed Quote Nasdaq, April 22, 2024 at 04:00 pm EDT
More quotes
Align Technology, Inc. specializes in the design, manufacturing and marketing of dental and medical devices. Net sales break down by family of products as follows:
- clear aligners (82.8%): sold under the brand name Invisalign;
- intra-oral scanners (17.2%): iTero. The group also offers scanner services.
Net sales are distributed geographically as follows: the United States (43.1%), Switzerland (30.3%), and other (26.6%).
Calendar
2024-04-24
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
300.8
USD
Average target price
321
USD
Spread / Average Target
+6.69%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +9.79% | 22.64B | |
| -2.73% | 186B | |
| -2.20% | 107B | |
| -4.08% | 67.57B | |
| +5.99% | 50.7B | |
| +15.32% | 47.2B | |
| -0.45% | 39.72B | |
| +6.60% | 27.48B | |
| -1.11% | 25.65B | |
| -0.76% | 24.82B |
- Stock Market
- Equities
- ALGN Stock
